Aquaporin Reduces Revenue Projections for 2025 But Holds Steady on EBITDA Expectations

Aquaporin Lowers Revenue Guidance for 2025: What It Means

Aquaporin A/S, a pioneering water technology company headquartered in Denmark, has recently adjusted its financial outlook for 2025, lowering its revenue guidance from the previously expected DKK 60-80 million to a new estimate of DKK 40-50 million. This decision comes as the company faces challenges related to a slower than anticipated inflow of orders and certain order delays. However, while revenue forecasts have been modified, the company has confirmed that its EBITDA guidance will remain unchanged, projecting a loss in the range of DKK 45-55 million. This strategic pivot is intended to fortify Aquaporin's financial structure as it navigates the current market conditions.

The revised revenue expectations highlight Aquaporin’s operational focus across three main business sectors: Residential Drinking Water, Industrial Water, and Forward Osmosis Market Development. The company anticipates that each of these segments will contribute approximately equally to revenue in 2025. Despite the updated figures, CEO Ulrik Lund Jakobsen expressed a confident outlook, emphasizing the strong foundation that Aquaporin has built for future commercial success. He stated, "Although the run-up to materialize orders in 2025 has been slower than expected, I believe Aquaporin has a strong foundation in terms of pipeline and potential to progress its commercial traction in the coming years."

Additionally, the second half of 2025 is expected to account for the bulk of the revenue, aligned with the company’s previous patterns. Ulrik highlighted the necessity of a strategic review to explore various avenues for raising capital, which may include options such as equity financing, debt options, or potential partnerships. This is aimed towards ensuring that the company is sufficiently capitalized for growth beyond 2025.

Aquaporin is renowned for its innovative approach to water filtration through biotechnology, leveraging nature-inspired solutions encapsulated in its Aquaporin Inside® technology. This unique technology stems from Nobel Prize-winning research and has applications in multiple sectors, including cleaning industrial wastewater, enhancing drinking quality, and even usage by NASA for water filtration in space. The company's commitment to addressing global water challenges has made it a key player in the market.

In conclusion, while the lowered revenue guidance may raise concerns among stakeholders, Aquaporin's unwavering EBITDA projections and proactive strategic review signal the company's determination to adapt and thrive in a competitive landscape. Stakeholders and analysts will be keenly awaiting the upcoming Half-Year Interim Report 2025, set for publication on August 21, 2025, which may offer further insights into the company's operational strategies and future projections. For further inquiries about Aquaporin’s operations and strategies, stakeholders can contact CEO Ulrik Lund Jakobsen or CFO Klaus Juhl Wulff. Their efforts are focused on ensuring the company's readiness to meet future challenges in the water industry.

This shift in financial expectations underscores the dynamic nature of the water technology sector and the importance of adaptability in operational strategies for sustained growth.